Kenya ePrescription FHIR Implementation Guide
0.1.0 - ci-build
Kenya ePrescription FHIR Implementation Guide
0.1.0 - ci-build
Kenya ePrescription FHIR Implementation Guide - Local Development build (v0.1.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
| Official URL: https://nshr-uat.sha.go.ke/fhir/ValueSet/icd11 | Version: 0.1.0 | |||
| Active as of 2026-05-31 | Computable Name: ICD11VS | |||
Copyright/Legal: Copyright 2025+ Digital Health Agency, Kenya. This content is licensed under Creative Commons Attribution 4.0 International (CC-BY-4.0). Terminology content from the Kenya Pharmacy and Poisons Board (PPB) via Open Concept Lab (OCL) is subject to separate terms. |
||||
All codes from the WHO International Classification of Diseases, 11th Revision (ICD-11).
References
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs version 📦0.1.0
Expansion performed internally based on codesystem ICD-11 Code System v0.1.0 (CodeSystem)
This value set contains 1,000 concepts
| System | Code | Display (en) | JSON | XML |
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | mms | ICD-11 for Mortality and Morbidity Statistics | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1630407678 | Neoplasms | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1766440644 | Diseases of the blood or blood-forming organs | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1954798891 | Diseases of the immune system | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1435254666 | Certain infectious or parasitic diseases | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 21500692 | Endocrine, nutritional or metabolic diseases | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A00-2A0Z | Neoplasms of central nervous system or related structures | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B50-2E2Z | Malignant neoplasms, except primary neoplasms of lymphoid, haematopoietic, central nervous system or related tissues | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A20-2B3Z | Neoplasms of haematopoietic or lymphoid tissues | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E60-2E6Z | In situ neoplasms, except of lymphoid, haematopoietic, central nervous system or related tissues | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E80-2F3Z | Benign neoplasms, except of lymphoid, haematopoietic, central nervous system or related tissues | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E62 | Carcinoma in situ of middle ear or respiratory system | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E61 | Carcinoma in situ of other or unspecified digestive organs | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E60 | Carcinoma in situ of oral cavity, oesophagus or stomach | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E90-2F3Z | Benign neoplasms except of mesenchymal origin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E80-2E8Z | Benign mesenchymal neoplasms | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B70-1B7Z | Pyogenic bacterial infections of the skin or subcutaneous tissues | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B10-1B2Z | Mycobacterial diseases | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A60-1A9Z | Predominantly sexually transmitted infections | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A00-1A40.Z | Gastroenteritis or colitis of infectious origin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E64 | Carcinoma in situ of skin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E63 | Melanoma in situ neoplasms | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B40-1B5Z | Certain staphylococcal or streptococcal diseases | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 5B50-5C3Z | Nutritional disorders | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 5C50-5D2Z | Metabolic disorders | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 5D40-5D46 | Postprocedural endocrine or metabolic disorders | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 5A00-5B3Z | Endocrine diseases | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E81 | Benign vascular neoplasms | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E84 | Benign fibrogenic or myofibrogenic tumour | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E80 | Benign lipomatous neoplasm | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E92 | Benign neoplasm of digestive organs | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E90 | Benign neoplasm of lip, oral cavity or pharynx | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2F00-2F01 | Benign neoplasm of middle ear, respiratory or intrathoracic organs | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E91 | Benign neoplasm of major salivary glands | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B10-1B1Z | Tuberculosis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2F10 | Fibrous benign mesothelioma of omentum | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E83 | Benign osteogenic tumours | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B74 | Superficial bacterial folliculitis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2D50-2E2Z | Malignant neoplasm metastases | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B70 | Bacterial cellulitis, erysipelas or lymphangitis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B71 | Necrotising fasciitis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A20-1A2Z | Viral intestinal infections | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A30-1A3Z | Protozoal intestinal infections | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B72 | Impetigo | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B73 | Ecthyma | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E82 | Benign chondrogenic tumours | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2D40-2D4Z | Malignant neoplasms of ill-defined or unspecified primary sites | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B50-2D3Z | Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic, central nervous system or related tissues | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B21 | Infections due to non-tuberculous mycobacteria | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B20 | Leprosy | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E63.0 | Melanoma in situ of skin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B2Y | Other specified mycobacterial diseases | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B54 | Staphylococcal spinal meningitis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B50 | Otitis media in scarlet fever | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B53 | Meningitis due to Streptococcus agalactiae | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B40-1B42 | Acute rheumatic fever | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B51 | acute streptococcal ulcerated sore throat | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A00-1A0Z | Bacterial intestinal infections | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A10-1A1Z | Bacterial foodborne intoxications | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E63.1 | Melanoma in situ of conjunctiva | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E63.Y | Melanoma in situ neoplasms, other specified site | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B2Z | Mycobacterial diseases, unspecified | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E63.Z | precancerous melanosis of unspecified site | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A40 | Gastroenteritis or colitis without specification of infectious agent | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A60-4A6Z | Autoinflammatory disorders | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A20 | Acquired immunodeficiencies | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A80-4A8Z | Allergic or hypersensitivity conditions | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A40-4A4Z | Nonorgan specific systemic autoimmune disorders | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A00-4A0Z | Primary immunodeficiencies | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E61.3 | gallbladder carcinoma in situ | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E60.2 | Carcinoma in situ of intraepithelium of stomach | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E60.1 | Glandular intraepithelial neoplasia of oesophagus, high grade | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E61.0 | Carcinoma in situ of rectosigmoid junction | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E61.2 | AIN - [anal intraepithelial neoplasia] high grade | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E61.1 | Intraepithelial neoplasia (dysplasia) of rectum, high grade | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E61.Y | Carcinoma in situ of tail of pancreas | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E62.2 | pulmonary carcinoma in situ | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E62.Z | Carcinoma in situ of middle ear or respiratory system | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E62.Y | Carcinoma in situ of vestibule of nose | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E62.0 | Carcinoma in situ of thyroid cartilage | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E60.0 | Carcinoma in situ upper labial sulcus | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E62.1 | Intraepithelial neoplasia (dysplasia) of trachea, high grade | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A00 | Primary neoplasms of brain | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A02 | Primary neoplasm of spinal cord, cranial nerves, paraspinal nerves or remaining parts of central nervous system | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A0Z | Nonpolyposis Turcot syndrome | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A01 | primary neoplasm of spinal meninges | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 5B50-5B7Z | Undernutrition | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 5C3Y | Skin disorder attributable to food fads or unhealthy diet | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 5C3Z | Nutritional liver disease, not elsewhere classified | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E64.0 | Intraepidermal squamous cell carcinoma | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 5B80-5C1Z | Overweight, obesity or specific nutrient excesses | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E64.Z | skin carcinoma in situ | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E64.1 | Extramammary Paget disease of anogenital skin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E64.Y | Apocrine adenocarcinoma in situ of unspecified site | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E64.2 | High grade squamous intraepithelial lesion of anal margin or perianal skin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 5D40 | Postprocedural hypothyroidism | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 5D41 | Postpancreatectomy hyperglycaemia | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 5A50-5A5Z | Disorders of the parathyroids or parathyroid hormone system | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 5D42 | Parathyroprival tetany | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 5D43 | Postirradiation hypopituitarism | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 5D44 | iatrogenic ovarian failure | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 5A40-5A4Z | Other disorders of glucose regulation or pancreatic internal secretion | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 5A10-5A2Y | Diabetes mellitus | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 5A60-5A6Z | Disorders of the pituitary hormone system | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 5A00-5A0Z | Disorders of the thyroid gland or thyroid hormones system | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E84.0 | Benign fibrogenic or myofibrogenic tumour of skin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E84.Z | Myxoma of unspecified site | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E84.Y | Benign fibrogenic or myofibrogenic tumour of other specified sites | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E80.Y | Other specified benign lipomatous neoplasm | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E80.1 | Lipoblastoma | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E80.0 | Lipoma | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E80.Z | Benign adipocytic tumour | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E92.4 | Benign neoplasm of the large intestine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E92.2 | Other benign neoplasm of duodenum | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E92.1 | benign tumour of pylorus | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2F00 | Benign neoplasm of middle ear or respiratory system | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E90.3 | Benign tumour of internal cheek | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E92.0 | benign tumour of upper third of oesophagus | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E92.3 | benign tumour of ileal diverticulum | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E83.2 | benign neoplasm of vertebra | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E90.2 | benign tumour of floor of mouth | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E83.3 | benign neoplasm of clavicle | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E90.1 | Granular cell myoblastoma of tongue | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E90.4 | benign tumour of tonsil | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B71.0 | Necrotising fasciitis type 2 | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E90.0 | Benign tumour of upper labial mucosa | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2F01 | Benign neoplasm of visceral pleura | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E83.0 | Upper jaw dentinoma | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2F20-2F2Z | Benign cutaneous neoplasms | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E83.1 | Periradicular cemental dysplasia of lower jaw | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E83.4 | Benign neoplasm of sacrum | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2D70-2D7Z | Malignant neoplasm metastasis in thoracic or respiratory organs | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B74.Z | Superficial folliculitis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B74.0 | Follicular impetigo of Bockhart | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B71.1 | Progressive bacterial synergistic gangrene | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B71.2 | Neonatal streptococcal necrotising fasciitis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2D52 | Malignant neoplasm metastasis in epidural space | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2D60-2D6Z | Malignant neoplasm metastasis in lymph nodes | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2D50 | Malignant neoplasm metastasis in choroid plexus | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B71.Z | necrotizing fasciitis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2D51 | spinal arachnoid metastasis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B71.Y | Necrotising fasciitis, trunk | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A31 | Colitis due to Giardia lamblia | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A33 | Cystoisosporiasis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B74.Y | Hot tub folliculitis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A34 | sarcosporidiasis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E82.0 | Benign chondrogenic tumours of bone or articular cartilage of limbs | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A32 | Cryptosporidial colitis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A30 | Balantidium coli anaemia | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E82.Z | giant cell chondromatous tumour of unspecified site | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2C30-2C3Z | Malignant neoplasms of skin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B70-2C1Z | Malignant neoplasms of digestive organs | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E82.1 | Benign chondrogenic tumours of bone or articular cartilage of other specified sites | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B73.Z | Ecthyma | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B73.2 | Ecthyma gangrenosum | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B73.1 | Staphylococcal ecthyma | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B73.0 | Streptococcal ecthyma | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B60-2B6Y | Malignant neoplasms of lip, oral cavity or pharynx | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2C20-2C2Z | Malignant neoplasms of middle ear, respiratory or intrathoracic organs | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B73.Y | Other specified ecthyma | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B50-2B5Z | Malignant mesenchymal neoplasms | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B20.2 | Leprosy reactions | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B20.3 | Mycobacterium leprae dacryoadenitis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B20.Z | leprosy unspecified | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B20.1 | Hansen disease, diffuse lepromatous | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E63.00 | Hutchinson melanotic freckle | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E63.0Z | Radial growth phase malignant melanoma | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B5Y | Staphylococcal pericarditis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B20.0 | BT - [borderline tuberculoid] leprosy | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B40 | Acute rheumatic fever without mention of heart involvement | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B41 | Acute rheumatic fever with heart involvement | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B42 | ST Vitus dance | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B5Z | sepsis due to group B Strep without mention of septic shock | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A61 | SAPHO - [synovitis, acne, pustulosis, hyperostosis, osteitis] syndrome | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A6Z | Autoinflammatory disorders, unspecified | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A6Y | Juvenile chronic recurrent multifocal osteomyelitis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A60 | Monogenic autoinflammatory syndromes | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A20.1 | Acquired immunodeficiency due to protein loss | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A62 | Neurological complications of Behçet disease | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A20.Z | Acquired immunodeficiencies | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A20.Y | Other specified acquired immunodeficiencies | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A84 | Anaphylaxis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A80 | Allergic or hypersensitivity disorders involving the respiratory tract | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A20.0 | Adult-onset immunodeficiency | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A83 | Allergic or hypersensitivity disorders involving the gastrointestinal tract | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A82 | Arthus phenomenon | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A81 | Ocular allergy | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A41 | Idiopathic inflammatory myopathy | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A43 | Overlap or undifferentiated nonorgan specific systemic autoimmune disease | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A42 | Systemic sclerosis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A44 | Vasculitis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A40 | Lupus erythematosus | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E61.Z | Carcinoma in situ of other or unspecified digestive organs | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A0Y | Lymphocyte function antigen-1 [LFA-1] defect | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A0Z | Primary immunodeficiencies, unspecified | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A01 | Primary immunodeficiencies due to disorders of adaptive immunity | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A00 | Primary immunodeficiencies due to disorders of innate immunity | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A90 | Chancroidal lymphadenitis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A91 | Osteomyelitis due to Klebsiella granuloma inguinale | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A70-1A7Z | Gonococcal infection | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A60-1A6Z | Syphilis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A80-1A8Z | Sexually transmissible infections due to chlamydia | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A00.3 | Central neurocytoma of brain | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A00.4 | astroblastoma of unspecified site | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A00.2 | Tumours of neuroepithelial tissue of brain | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A00.1 | Embryonal tumours of brain | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A00.0 | Gliomas of brain | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A02.4 | Benign neoplasm of cauda equina | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A02.0 | Gliomas of spinal cord, cranial or paraspinal nerves | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A02.2 | primary malignant neoplasm of cauda equina | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A01.0 | Meningiomas | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A02.1 | Tumours of cranial or paraspinal nerves | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A02.3 | acoustic neurinoma | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A01.2 | Neoplasm of uncertain or unknown behaviour of spinal meninges | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A01.1 | Mesenchymal tumours of meninges | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A20-2A2Z | Myeloproliferative neoplasms | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A40-2A4Z | Myelodysplastic and myeloproliferative neoplasms | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A60 | Acute myeloid leukaemias and related precursor neoplasms | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A30-2A3Z | Myelodysplastic syndromes | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A50-2A5Z | Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1 | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E91.0 | benign tumour of parotid gland | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E91.Z | Warthin tumour of unspecified site | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B12 | Tuberculosis of other systems and organs | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B13 | Miliary tuberculosis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B11 | Tuberculosis of the nervous system | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E91.1 | Benign neoplasm of submaxillary gland | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B14 | Carrier of Mycobacterium tuberculosis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B10 | Tuberculosis of the respiratory system | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B70.0 | Erysipelas | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B70.2 | Staphylococcal cellulitis of skin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B70.3 | Ascending bacterial lymphangitis due to Staphylococcus aureus | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B70.Y | Bacterial cellulitis or lymphangitis due to other specified bacterium | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B70.1 | Streptococcal cellulitis of the vulva and vagina | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A22 | rotaviral enteritis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A20 | Adenoviral enteritis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A24 | Gastroenteritis due to Cytomegalovirus | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A21 | infections due to Astrovirus | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2D44 | metastatic cancer, unknown origin, so stated | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2D41 | Metastatic carcinoma [primary carcinoma spreading elsewhere] | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A23 | Noroviral enteritis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2D43 | Malignant neoplasms of independent, multiple primary sites | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2D40 | Villous adenocarcinoma in adenoma of unspecified site | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2D42 | calf cancer | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E64.00 | Bowen type intraepidermal squamous cell carcinoma | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E64.0Y | Other specified intraepidermal squamous cell carcinoma | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E64.01 | Intraepidermal squamous cell carcinoma arising from actinic keratosis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E64.0Z | IEC - [intraepidermal carcinoma] | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 5B90-5B9Z | Certain specified nutrient excesses | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 5B80-5B81.Z | Overweight or obesity | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 5C1Z | Overweight, obesity or specific nutrient excesses, unspecified | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 5C1Y | late effect of hyperalimentation | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 5D40.Y | Other specified postprocedural hypothyroidism | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 5D40.0 | Postirridation hypothyroidism | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 5D40.Z | hypothyroidism due to absence of thyroid | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 5D45 | Postprocedural testicular hypofunction | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 5D46 | adrenalectomy status | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 5A60 | Hyperfunction of pituitary gland | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 5A61 | hypothalamic lesion | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 5A6Z | Disorders of the pituitary hormone system, unspecified | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 5A11 | insulin resistant diabetes | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 5A10 | SPIDDM - [Slowly progressive insulin-dependent diabetes mellitus] | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 5A13 | Other specified Diabetes mellitus, not Type 1 and not Type 2 | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 5A14 | Diabetes without mention of type of diabetes mellitus | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 5A00 | Hypothyroidism | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 5A02 | Thyrotoxicosis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 5A12 | malnutrition-related diabetes mellitus without complications | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 5A04 | C-cell hyperplasia of thyroid | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 5A03 | Thyroiditis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 5A01 | Nontoxic goitre | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E85 | Benign fibrohistiocytic tumour | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E80.00 | Superficial subcutaneous lipoma | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E80.0Y | Lipoma, other specified site | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E80.01 | Benign lipoma of spermatic cord | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E80.02 | Deep internal benign lipoma of retroperitoneum | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E80.0Z | Spindle cell lipoma of unspecified site | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E92.4Z | benign tumor of large intestine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E92.40 | HMPS - [hereditary mixed polyposis syndrome] | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E92.4Y | Tubular adenoma of sigmoid | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2F00.Z | Benign neoplasm of middle ear or respiratory system | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2F00.0 | Middle ear neuroendocrine tumour | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2F00.1 | Recurrent respiratory papillomatosis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E92.5 | Benign anorectal neoplasm | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E92.6 | Other benign neoplasms of gallbladder, extrahepatic bile duct or ampulla of Vater | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2F00.2 | Laryngeal neuroendocrine tumour | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E92.7 | biliary ductal cystadenoma | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2F00.Y | Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E90.5 | Benign tumour of mesopharynx | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E83.5 | Benign neoplasm of patella | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E90.6 | Benign neoplasm of the pharyngeal tonsil | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2F21 | Benign keratinocytic acanthomas | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2F20 | Benign cutaneous melanocytic neoplasms | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2F23 | Benign dermal fibrous or fibrohistiocytic neoplasms | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2F24 | Cellular neurothekeoma | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E83.Y | Benign osteogenic tumour of other specified site | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2D71 | mediastinum metastasis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2D72 | pleural metastasis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2D7Y | tracheal cartilage metastasis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2F22 | Tubular papillary adenoma | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2D70 | Metastatic carcinoma in lung | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2D73 | Malignant neoplasm metastasis in false vocal cord | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E83.Z | Osteoma of unspecified site | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2D90-2D91 | Malignant neoplasm metastasis in retroperitoneum or peritoneum | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2D80-2D8Z | Malignant neoplasm metastasis in digestive system | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E00-2E0Y | Malignant neoplasm metastasis in other specified sites | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A33.0 | Infection due to Isopora belli | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A33.1 | coccidial colitis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B75 | Deep bacterial folliculitis or pyogenic abscess of the skin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A35 | Blastocystosis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A33.Y | Other specified cystoisosporiasis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A36 | Amoebiasis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A33.Z | Isosporiasis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A3Z | Protozoal intestinal infections, unspecified | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A3Y | embadomonas dysentery | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E86 | Benign smooth muscle or skeletal muscle tumour | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B7Y | Skin infection classified elsewhere due to hospital-acquired MRSA | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B20.20 | Leprosy upgrading reaction | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B20.21 | Lucio phenomenon | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E65 | Carcinoma in situ of breast | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B40.0 | acute articular rheumatism | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B40.Z | subacute rheumatic fever | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B40.Y | rheumatic pneumonitis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E81.Y | Other specified benign vascular neoplasms | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E81.2 | Benign vascular neoplasms of infancy or childhood | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E81.0 | Neoplastic haemangioma | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E81.Z | Benign vascular neoplasms | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E81.1 | Benign lymphatic neoplasms | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A60.2 | Tumour necrosis factor receptor 1 associated periodic syndrome with amyloidosis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A60.1 | Muckle Wells Syndrome with neurosensorial hearing loss | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A60.0 | Familial Mediterranean fever with amyloidosis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A60.Z | Monogenic autoinflammatory syndromes | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A60.Y | NLRP12-associated hereditary periodic fever syndrome | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A84.0 | Anaphylactic shock due to allergic food reaction | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A84.3 | Anaphylaxis provoked by physical factors | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A84.2 | Insect venom allergen-induced anaphylaxis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A84.4 | Inhaled allergen-induced anaphylaxis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A84.1 | medicament-induced anaphylaxis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4B00-4B0Z | Immune system disorders involving white cell lineages | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A80.Y | Other specified allergic or hypersensitivity disorders involving the respiratory tract | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A80.1 | Food-induced wheezing | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A80.Z | Allergic or hypersensitivity disorders involving the respiratory tract | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A80.0 | medicament-induced bronchospasm | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A83.1 | Food-induced eosinophilic oesophagitis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A83.Y | Other specified allergic or hypersensitivity disorders involving the gastrointestinal tract | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A83.Z | Allergic or hypersensitivity disorders involving the gastrointestinal tract | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A83.0 | Food-induced eosinophilic gastroenteritis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A85 | Complex allergic or hypersensitivity conditions | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A8Y | Allergic or hypersensitivity conditions of other specified type | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A41.0 | Dermatomyositis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A41.Y | Focal myositis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A41.2 | Inclusion body myopathy | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A41.1 | Polymyositis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A41.Z | Idiopathic inflammatory myopathy | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A43.2 | Sjögren syndrome | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A43.3 | Paediatric-onset MCTD - [mixed connective tissue disease] | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A44.2 | Giant cell arteritis without polymyalgia rheumatica | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A43.1 | Mikulicz disease | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A43.0 | Cholangitis of IgG4-related sclerosing disease | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A43.4 | Diffuse fasciitis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A40.1 | drug-induced systemic lupus erythematosus | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A44.0 | Rhizomelic pseudopolyarthritis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A44.3 | Single organ vasculitis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A40.Y | Lupus erythematosus of oral mucosa | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A40.0 | Systemic lupus erythematosus | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A44.4 | Periarteritis nodosa with necrosis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A44.1 | young female aortic arch arteritis syndrome | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A40.Z | LE - [lupus erythematosus] | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A01.1 | Combined immunodeficiencies | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A01.2 | Diseases of immune dysregulation | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A01.0 | Immunodeficiencies with predominantly antibody defects | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A01.Z | Primary immunodeficiencies due to disorders of adaptive immunity | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A01.3 | Other well-defined immunodeficiency syndromes due to defects in adaptive immunity | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A00.1 | Defects in the complement system | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A00.3 | Immunodeficiency with NK-cell - [natural-killer cell] deficiency | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A00.Y | Warts - hypogammaglobulinaemia - infections - myelokathexis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A00.2 | Pyogenic bacterial infections due to MyD88 deficiency | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A00.0 | Functional neutrophil defects | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A93 | Sexually transmissible infestations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A92 | Trichomonal cervicitis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A60 | Congenital syphilis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A61 | Early syphilis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A63 | Positive Wassermann test | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A6Z | Female syphilitic pelvic inflammatory disease | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A62 | Late syphilis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B72.0 | Blistering distal dactylitis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B72.Y | Other specified impetigo | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B72.1 | Non-bullous impetigo | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B21.1 | Non-tuberculous mycobacterial lymphadenitis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B21.0 | Pulmonary infection due to Mycobacterium malmoense | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B21.4 | Non-tuberculous mycobacterial colitis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A00.20 | Pineocytoma | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A00.21 | Lhermitte-Duclos disease | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A00.22 | choroid plexus carcinoma (grade 3 lesion) | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A00.2Y | Other specified tumours of neuroepithelial tissue of brain | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A00.0Z | glioma NOS | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A00.2Z | Tumours of neuroepithelial tissue of brain | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A00.5 | benign brain tumour NOS | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A00.1Y | Yolk sac tumour of the central nervous system | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B21.3 | DMAC - [disseminated mycobacterium avium-intracellulare complex infection] | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A02.00 | Glioblastoma of spinal cord, cranial or paraspinal nerves | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A02.0Z | Gliomas of spinal cord, cranial or paraspinal nerves | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A02.0Y | Malignant astrocytomas of spinal cord, cranial or paraspinal nerves | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A00.00 | Spongioblastoma multiforme of unspecified site | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A00.10 | Neuroepithelioma | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A00.1Z | Embryonal tumours of brain | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A00.0Y | Subependymal glioma, unspecified site | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A02.10 | neurofibrosarcoma | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A00.11 | Teratoid medulloepithelioma of unspecified site | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A20 | Non mast cell myeloproliferative neoplasms | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A60.4 | Myeloid proliferation associated with Down syndrome | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A60.1 | Acute myeloid leukaemia with multilineage dysplasia in complete remission | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A60.2 | Therapy-related myeloid neoplasms | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A40 | CMML-2 - [chronic myelomonocytic leukaemia Type 2] | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A60.0 | Acute myeloid leukemia with t(8;21)(q22;q22) translocation | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A41 | Atypical chronic myeloid leukaemia, BCR-ABL1-negative in complete remission | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B12.2 | Tuberculosis of inner ear | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B12.0 | tuberculous pericarditis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A01.0Z | benign meningioma (deprecated) | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A2Z | myeloproliferative disorder | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B1Y | Disorders of kidney or ureter in tuberculosis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B11.1 | Tuberculous meningoencephalitis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A60.3 | Acute myeloid leukaemia, not elsewhere classified by criteria of other types | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B11.2 | Tuberculoma of spinal meninges | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A43 | RARS-T [Refractory anaemia with ringed sideroblasts associated with marked thrombocytosis](provisional) | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A42 | Juvenile myelomonocytic leukaemia | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A44 | Myeloproliferative and myelodysplastic disease, unclassifiable in complete remission | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A51 | Myeloid neoplasms with PDGFRB rearrangement | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A02.Z | Epidural cancer NOS | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B13.2 | Acute miliary tuberculosis, unspecified site | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B13.1 | tuberculous polyserositis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B13.Y | Chronic multiple tuberculosis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B13.Z | disseminated tuberculosis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B11.3 | tuberculoma of brain | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B11.0 | spinal meningeal TBC - [tuberculosis] | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B11.Y | tuberculous cerebrum arteritis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A01.0Y | Syncytial meningioma of unspecified site | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A2Y | chronic myeloproliferative disease NOS | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A40.0 | jejunal inflammation | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E92.8 | benign tumour of tail of pancreas | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A40.Z | intestinal infections without specification of infectious agent | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B13.0 | Acute miliary lung TBC - [tuberculosis] | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2F30 | Benign neoplasm of breast | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B10.0 | Tuberculous sinusitis of any sinus, with bacteriological and histological confirmation | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B7Z | suppurative dermatitis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B12.5 | Tuberculosis of breast | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B10.Z | Tuberculous pansinusitis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2D61 | Malignant neoplasm metastasis in lymph nodes of multiple regions by adenocarcinoma | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2D6Z | lymphatic vessel metastasis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B70.Z | Cellulitis not otherwise specified | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E81.2Y | Diffuse neonatal haemangiomatosis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E90.7 | Benign tumour of pharyngoesophageal junction | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A2Z | Viral gastroenteropathy NOS | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E81.21 | Multiple strawberry haemangiomata | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B12.6 | TB - [tuberculosis] axillary gland | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B63 | Malignant neoplasms of gum | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B64 | Malignant neoplasms of floor of mouth | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B61 | Malignant neoplasms of base of tongue | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E66 | Carcinoma in situ of cervix uteri | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2D60 | Malignant neoplasm metastasis in lymph node of a single region | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 5B80 | Overweight or localised adiposity | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 5B81 | Obesity | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 5B90 | Vitamin excesses | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A2Y | Enteritis due to coxsackievirus | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B12.8 | Tuberculous gumma | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 5A05 | Refetoff syndrome | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2F20.Y | Unclassifiable benign cutaneous melanocytic proliferation | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 5B91 | Mineral excesses | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 5B9Z | Nutrient excesses, unspecified | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2D4Z | Cancer in polyp | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B60 | Malignant neoplasms of lip | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B62 | Malignant neoplasms of other or unspecified parts of tongue | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 5A00.0 | Congenital hypothyroidism | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 5A00.Z | Subclinical hypothyroidism | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 5A00.1 | Iodine-deficiency-related thyroid disorders or allied conditions | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 5A20-5A2Y | Acute complications of diabetes mellitus | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A43.Y | Other specified non-organ specific systemic autoimmune disorders, not elsewhere classified, associated with anti-RNP antibodies | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E87 | GIST - [gastrointestinal stromal tumour] of appendix | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 5D40.0Z | Postirridation hypothyroidism | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2F20.2 | Congenital melanocytic naevus | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2F20.3 | Generalised eruptive melanocytic naevi | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2F20.1 | Melanocytic naevus with mild to moderate dysplasia | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2F20.Z | Naevus pigmentosus | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 5B9Y | Other specified nutrient excesses | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E92.Y | Benign neoplasm of other specified digestive organs | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A42.Z | Myopathy in scleroderma | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2F21.0 | Traumatized seborrhoeic keratosis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2F25 | de Morgan's spots | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2F23.0 | Subepidermal nodular fibrosis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2F23.Y | Fibrous papule of nose | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E90.8 | benign tumour of Waldeyer ring | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E88 | Stromal nodule | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E92.Z | benign tumour of intestine NOS | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A42.2 | CRST - [calcinosis, Raynaud phenomenon, sclerodactyly and telangiectasia] syndrome | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2D80 | Secondary malignant neoplasm of liver or intrahepatic bile duct | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2D84 | duodenal metastasis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2D82 | metastasis to ductus choledochus | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2F26 | Pyogenic granuloma | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A70 | Gonococcal genitourinary infection | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2D90 | secondary malignant neoplasm of retroperitoneum | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B75.0 | Boil | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B75.2 | Furunculosis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2D91 | malignant ascites NOS | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A01.30 | Immunodeficiency due to absence of thymus | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A01.32 | Schimke syndrome | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E86.2 | Glycogenic rhabdomyoma | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A72 | Gonococcal infection of other sites | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A36.Z | amoebiasis, unspecified | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A7Z | Infection due to Neisseria gonorrhoeae | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2D7Z | thorax metastasis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A01.33 | VODI - [Veno-occlusive disease immunodeficiency] syndrome | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A01.31 | ATLD - [Ataxia-telangiectasia-like disorder] | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 4A01.34 | Hyperimmunoglobulin E syndrome due to TYK2 deficiency | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E86.Z | myoma of unspecified site | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A36.0 | Intestinal infections due to Entamoeba | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2D86 | anal canal metastasis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B75.3 | abscess NOS | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B75.1 | Carbuncle | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A00-3A9Z | Anaemias or other erythrocyte disorders | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A30 | refractory anaemia without sideroblasts | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3B10-3B6Z | Coagulation defects, purpura or other haemorrhagic or related conditions | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3B80-3B8Z | Diseases of spleen | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A01.00 | Familial multiple meningioma | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A10 | staphylococcus poisoning | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A00 | Cholera due to Vibrio cholerae O139 | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B21.2 | Cutaneous non-tuberculous mycobacterial infection | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A71 | Gonococcal ovarian abscess | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A12 | pigbel | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B50 | Chondrosarcoma, primary site | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A32 | Refractory thrombocytopenia | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A31 | Refractory neutropaenia | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B52 | Ewing sarcoma, primary site | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A70.0 | Gonococcal infection of lower genitourinary tract without periurethral or accessory gland abscess | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A21 | Mastocytosis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A70.1 | Gonococcal abscess of penis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A02 | Sepsis due to shigella with septic shock | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A81 | Non-ulcerative sexually transmitted chlamydial infection | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A60.1 | Early congenital syphilis, latent | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A8Y | Other specified sexually transmissible infections due to chlamydia | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A01 | Infections due to Vibrio vulnificus | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A80 | chlamydial lymphogranuloma venereum | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B10.1 | tuberculous pleural effusion, not confirmed | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A11 | Botulism | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A72.1 | Infection of the rectum due to Neisseria gonorrhoeae | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A72.2 | Infection of the anus due to Neisseria gonorrhoeae | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A02.11 | paraspinous neuroblastoma | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A70.Y | Chronic gonococcal prostatitis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B71 | Malignant neoplasms of oesophagogastric junction | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A72.0 | Gonococcal spondylitis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A61.1 | primary syphilis of anus | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B72 | Malignant neoplasms of stomach | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A02.12 | Other specified malignant neoplasms of optic nerve | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B70 | Malignant neoplasms of oesophagus | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A42.0 | Juvenile myelomonocytic leukaemia in complete remission | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A20.0 | Chronic myelogenous leukaemia, BCR-ABL1-positive | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A61.2 | primary syphilitic tonsils | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B21.Y | mycobacteriosis NOS | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A20.1 | Chronic neutrophilic leukaemia | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A20.2 | megakaryocytic myeloid metaplasia | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A4Y | Other specified myelodysplastic and myeloproliferative neoplasms | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A02.1Y | Olfactory groove meningioma | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2D4Y | Small cell carcinoma of unspecified site | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A4Z | Myelodysplastic and myeloproliferative neoplasms, unspecified | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B62.0 | Squamous cell carcinoma of tongue NOS | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B51 | Osteosarcoma, primary site | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2D60.2 | spleen lymph gland metastasis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A60.2 | Late congenital syphilitic chorioretinitis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B12.4 | Tuberculosis of the musculoskeletal system | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2D81 | secondary malignant neoplasm of pancreas | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B21.Z | MOTT - [mycobacteria other than tubercle bacilli] | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A61.0 | Urethral chancre | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A60.0 | Early congenital visceral syphilis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A42.Z | juvenile myelomonocytic leukaemia without mention of remission | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A42.Y | Other specified juvenile myelomonocytic leukaemia | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B61.Y | Other specified malignant neoplasms of base of tongue | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B12.1 | Tuberculous chorioretinitis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A62.1 | Syphilitic pulmonary aneurysm | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B61.0 | Squamous cell carcinoma of the base of the tongue | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2D60.0 | Supraclavicular lymph gland metastasis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B62.1 | Malignant neoplasms of lingual tonsil | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A62.2 | Symptomatic late syphilis of other sites | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A62.0 | Neurosyphilis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B60.1 | Squamous cell carcinoma of lip | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2D60.1 | Pulmonary lymph gland metastasis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B61.Z | malignant neoplasm of anterior two-thirds of tongue, dorsal surface | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2D83 | secondary malignant neoplasm of hepatopancreatic ampulla | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B60.0 | Basal cell carcinoma of lip | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B62.Y | Other specified malignant neoplasms of other or unspecified parts of tongue | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A36.1 | Extraintestinal infections due to Entamoeba | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2D80.0 | hepatic metastases | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2D80.1 | intrahepatic gall ductal metastasis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B60.Y | Other specified malignant neoplasms of lip | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B11.Z | CNS - [central nervous system] TB - [tuberculosis] | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B12.3 | Tuberculosis of pituitary gland | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E00 | renal pelvis metastasis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E02 | ureteral metastasis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A36.00 | Acute nondysenteric amebic enteritis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E01 | urinary bladder metastasis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A36.01 | Amoeboma of large intestine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A36.0Y | nondysenteric amebic diarrhoea | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A00-3A03.Y | Nutritional or metabolic anaemias | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A10-3A4Z | Haemolytic anaemias | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A50 | Thalassaemias | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A33 | Refractory anaemia with hemochromatosis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A13 | Foodborne intoxication due to Bacillus cereus | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3B81 | Acquired disorders of spleen | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3B8Z | splenopathy | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3B80 | Congenital disorders of spleen | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A21.0 | Systemic mastocytosis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A1Y | Foodborne Vibrio parahaemolyticus intoxication | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A21.1 | Cutaneous mastocytosis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A60.3 | Late congenital syphilitic polyneuropathy | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A21.2 | Mast cell sarcoma | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A70.Z | Gonococcal genitourinary infection | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A03 | Intestinal infections due to Escherichia coli | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A04 | megacolon due to Clostridium difficile | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A34 | refractory anaemia with sideroblasts with transformation | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A8Z | Sexually transmissible infections due to chlamydia, unspecified | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B52.1 | Ewing sarcoma of bone or articular cartilage of pelvis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A35 | RAEB 2 - [Refractory anaemia with excess of blasts type 2] | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B52.0 | Ewing sarcoma of bone or articular cartilage of limbs | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B52.2 | Ewing sarcoma of bone or articular cartilage of ribs | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A05 | Colitis due to Yersinia enterocolitica | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A72.3 | Acute gonococcal pharyngitis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A72.4 | Keratitis blennorrhagica | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A11.1 | Toxin-mediated infectious botulism | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A02.1Z | Primary malignant neoplasm of vagus nerve | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A11.Z | Disorders of the neuromuscular junction in botulism | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A11.0 | Foodborne Clostridium botulinum toxin intoxication | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A61.3 | Syphilitic alopecia | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B1Z | Tuberculosis attributable to Mycobacterium tuberculosis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A61.4 | Secondary syphilitic lymphadenitis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A20.3 | Chronic eosinophilic leukaemia, not elsewhere classified | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B51.0 | Osseous sarcomas of bone and articular cartilage of mandible | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B51.2 | Osseous sarcomas of bone and articular cartilage of pelvic bones, sacrum and coccyx | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B62.Z | primary malignant neoplasm of tongue | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B51.1 | Osteosarcoma of bone or articular cartilage of limbs | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B12.4Y | Tuberculosis of other specified part of the musculoskeletal system | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A60.4 | Congenital syphilitic stigmata | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B12.41 | Tuberculosis of skeletal muscle | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2D60.3 | Malignant neoplasm metastasis in axillary or arm lymph nodes by other or unspecified epithelial neoplasm | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A61.5 | latent syphilis, positive serology, early or less than 2 years after infection | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2D85 | ileocecum metastasis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A60.5 | Late congenital syphilis, latent | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A50 | Myeloid/lymphoid neoplasm associated with PDGFRA rearrangement | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A52 | Myeloid or lymphoid neoplasms with FGFR1 abnormalities | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B12.40 | Tuberculous rheumatism | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A5Z | Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1, unspecified | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2D60.4 | Malignant neoplasm metastasis in inguinal or leg lymph nodes by other or unspecified epithelial neoplasm | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B62.10 | Squamous cell carcinoma of lingual tonsil | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B62.1Z | primary malignant neoplasm of lingual tonsil | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A62.20 | Late syphilitic chorioretinitis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A62.00 | Asymptomatic neurosyphilis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A62.0Z | tertiary central nervous system syphilis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A62.22 | Syphilitic gumma | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2D60.5 | Iliac lymph gland metastasis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A62.01 | Syphilitic paraplegia | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A62.21 | Syphilis, stage unspecified, of synovium | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B60.Z | malignant neoplasm of lip, unspecified | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2D8Z | Malignant neoplasm metastasis in unspecified digestive system organ | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B63.0 | Squamous cell carcinoma of gum | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2D8Y | submandibular glandular metastasis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B63.Y | Malignant neoplasm of alveolar ridge mucosa | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B63.Z | primary malignant neoplasm of gum | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A36.10 | amoebic hepatitis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A36.11 | Amoebic abscess of lung and liver | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A36.12 | Amoebic ulcer of skin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3B50-3B51 | Fibrinolytic defects | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3B10-3B4Z | Coagulation defects | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3B60 | Non-thrombocytopenic purpura | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E04 | Malignant neoplasm metastasis in soft tissue of abdominal wall | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E03 | Metastatic fracture of unspecified site | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A36.0Z | Intestinal infections due to Entamoeba | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E05 | Malignant neoplasm metastasis in female reproductive system | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B50.0 | Chondrosarcoma of bone or articular cartilage of limbs | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B50.1 | Chondromatous sarcomas of bone and articular cartilage of pelvic bones, sacrum and coccyx | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B50.2 | Chondrosarcoma of bone or articular cartilage of ribs, sternum or clavicle | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A70.00 | Gonococcal lymphangitis of penis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A70.0Z | gonorrhoeal condyloma | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A00 | Iron deficiency anaemia | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A70.0Y | Gonococcal vulvovaginitis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A02 | Folate deficiency anaemia | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A01 | Megaloblastic anaemia due to vitamin B12 deficiency | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A10-3A1Y | Congenital haemolytic anaemia | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A20-3A2Z | Acquired haemolytic anaemia | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A4Z | Haemolytic anaemias, unspecified | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B71.0 | Adenocarcinoma of oesophagogastric junction | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B71.Z | primary malignant neoplasm of cardia of stomach | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A50.1 | Alpha-thalassaemia intellectual disability syndrome linked to chromosome 16 | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A50.0 | Alpha thalassaemia | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A50.2 | Beta-thalassemia-X-linked thrombocytopenia syndrome | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B70.1 | Squamous cell carcinomas of overlapping lesion of oesophagus | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B70.0 | Adenocarcinoma of oesophagus | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A1Z | food infection | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B71.Y | Other specified malignant neoplasm of oesophagogastric junction | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A36 | 5 q- syndrome | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B72.Y | metastatic gastric carcinoma [primary gastric carcinoma spreading elsewhere] | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B72.0 | Adenocarcinoma involving overlapping sites of stomach | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B72.1 | Gastrointestinal APUDomas | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B70.Y | Metastatic oesophageal carcinoma [primary oesophageal carcinoma spreading elsewhere] | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3B81.1 | acquired absence of spleen | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3B81.0 | SANT - [Sclerosing angiomatoid nodular transformation] | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3B81.2 | Degenerative diseases of the spleen | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A20.4 | primary polycythaemia | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A21.00 | Mast cell leukaemia in complete remission | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A21.0Y | Lymphoadenopathic mastocytosis with eosinophilia | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A21.3 | Extracutaneous mastocytoma | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A21.0Z | systemic tissue mast cell disease | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A21.10 | Maculopapular cutaneous mastocytosis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A21.1Z | Cutaneous mastocytosis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3B80.0 | Splenomegaly in storage diseases | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A21.1Y | Pseudoxanthomatous nodular cutaneous mastocytosis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A60.Z | Late congenital syphilis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A03.0 | Colitis in enteropathogenic Escherichia coli infection | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A37 | Myelodysplastic syndrome, unclassifiable | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A03.1 | Colitis in enterotoxigenic Escherichia coli infection | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A03.2 | Colitis in enteroinvasive Escherichia coli infection | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B52.3 | Malignant peripheral neuroectodermal tumour of cervix uteri | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B52.Y | Extraosseous Ewing sarcoma | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B52.Z | Ewing's sarcoma/peripheral neuroectodermal tumour [PNET] | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A38 | Refractory cytopenia of childhood | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A72.Y | Gonococcal skin lesions | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E65.1 | Lobular carcinoma in situ of breast, pleomorphic subtype | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A61.Y | Other specified early syphilis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E65.0 | Lobular carcinoma in situ of right breast | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E65.2 | Intraductal carcinoma in situ of left breast | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E66.Y | Squamous cell carcinoma in situ with questionable stromal invasion of unspecified site | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E66.Z | Carcinoma in situ of other parts of cervix | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E67 | Carcinoma in situ of other or unspecified genital organs | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E66.2 | cervical intraepithelial neoplasia grade II | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A20.5 | Non mast cell myeloproliferative neoplasm, unclassifiable | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A61.Z | general syphilis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A73 | Disseminated infection due to Neisseria gonorrhoeae | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B51.Y | Li-Fraumeni syndrome | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B51.Z | osteogenic sarcoma | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B12.4Z | Tuberculosis of the musculoskeletal system | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2D60.Y | Other specified malignant neoplasm metastasis in lymph node of a single region | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A60.20 | Acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A60.2Z | therapy-related myelodysplastic syndromes | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A60.2Y | Other specified therapy-related myeloid neoplasms | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A60.31 | Acute myeloblastic leukaemia without maturation | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A60.30 | Minimally differentiated acute myeloblastic leukaemia | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A60.40 | Transient abnormal myelopoiesis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A60.32 | Acute myeloblastic leukaemia with maturation | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A60.41 | Myeloid leukaemia associated with Down syndrome | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A60.4Y | Other specified myeloid proliferation associated with Down syndrome | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2D60.Z | Malignant neoplasm metastasis in lymph node of a single region | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B21.20 | Buruli ulcer | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B21.2Z | Atypical mycobacterial infection of the skin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B21.2Y | Cutaneous Mycobacterium kansasii infection | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B64.0 | Squamous cell carcinoma of floor of mouth | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B64.Z | primary malignant neoplasm of floor of mouth | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B64.Y | Other specified malignant neoplasm of floor of mouth | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A62.2Z | Symptomatic late syphilis of other sites | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A62.2Y | Late syphilitic peritonitis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A62.Y | Syphilis positive serology, late or 2 years or more after infection | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B65 | Malignant neoplasms of palate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B66 | Malignant neoplasms of other or unspecified parts of mouth | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A36.1Y | Amoebic vulvovaginitis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3B50 | Inherited fibrinolytic defects | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3B51 | Fibrinolytic disorder due to administration of other drugs | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3B10-3B1Z | Congenital or constitutional haemorrhagic condition | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3B20-3B2Y | Haemorrhagic diseases due to acquired coagulation factor defects | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3B4Z | coagulopathy NOS | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E06 | Malignant neoplasm metastasis in penis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E05.Z | Malignant neoplasm metastasis in female reproductive system | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E05.0 | Secondary mucinous adenocarcinoma of ovary | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E05.Y | vaginovesical septum metastasis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E07 | suprarenal gland metastasis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B12.7 | Tuberculous ascites | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B50.Z | chondrosarcoma NOS | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B50.Y | Chondromatous sarcomas of bone and articular cartilage of vertebral column | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A00.0 | Acquired iron deficiency anaemia due to blood loss | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A00.1 | Iron deficiency anaemia due to malnutrition | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A00.2 | Acquired iron deficiency anaemia due to coeliac disease | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A06 | Colitis due to Campylobacter | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A02.0 | Hereditary folate deficiency anaemia | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A02.2 | Acquired megaloblastic anaemia associated with psoriasis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A02.1 | megaloblastic anaemia due to poor nutrition | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A01.1 | Nutritional vitamin B12 deficiency due to maternal vitamin B12 deficiency in breast-fed infants | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A01.0 | Anaemia due to selective hereditary vitamin B12 malabsorption with proteinuria | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A01.2 | vegan anaemia NOS | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A1Y | congenital heinz body haemolytic anaemia | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A10 | Hereditary haemolytic anaemia | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A20 | Acquired haemolytic anaemia, immune | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A21 | Acquired haemolytic anaemia, non-immune | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A2Z | haemoglobinaemia | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A50.3 | Haemoglobin Lepore | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B70.Z | Metastatic oesophageal cancer [primary oesophageal cancer spreading elsewhere] | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B70.00 | Barrett adenocarcinoma | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B70.0Z | oesophageal adenocarcinoma | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B70.0Y | Adenocarcinoma involving overlapping sites of oesophagus | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B80-2C0Z | Malignant neoplasms of intestine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A3Y | Refractory anaemia with excess blasts in childhood | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B72.Z | cancer of pylorus of stomach | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3B81.5 | Splenic cyst or pseudocyst | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3B81.3 | Nontraumatic laceration or rupture of spleen | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3B81.4 | Splenosis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A20.Y | Other specified non mast cell myeloproliferative neoplasms | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A21.Y | Other specified mastocytosis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A21.Z | malignant mastocytosis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A03.3 | Colitis in enterohaemorrhagic Escherichia coli infection | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A3Z | preleukaemic syndrome | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A03.Y | EAEC - [Enteroaggregative Escherichia coli] infection | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A03.Z | Escherichia coli enteritis, not otherwise specified | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B53 | Fibroblastic or myofibroblastic tumour, primary site | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E65.3 | Ductal carcinoma in situ of breast, comedo subtype | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E65.4 | lobular with intraductal carcinoma in situ | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A20.02 | Chronic myelogenous leukaemia, t(9:22)(q34; q11) | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A20.01 | Chronic myelogenous leukaemia, Philadelphia chromosome (Ph1) positive | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A20.00 | Chronic myelogenous leukaemia with blast crisis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A20.Z | Non mast cell myeloproliferative neoplasms | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E68 | carcinoma in situ of urinary bladder | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B54 | Undifferentiated pleomorphic sarcoma, primary site | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B12.Y | Tuberculosis of adenoids, with bacteriological and histological confirmation | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A60.5 | agranular CD4+ NK leukaemia | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A60.33 | Acute myelomonocytic leukaemia in complete remission | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A60.4Z | Myeloid proliferation associated with Down syndrome | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A60.34 | AML M5b | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A60.35 | Acute erythroid leukaemia in complete remission | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E2Z | Secondary carcinoma of unspecified site | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B67 | Malignant neoplasms of parotid gland | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A62.Z | late tertiary syphilis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A07 | Typhoid fever | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3B10 | Hereditary factor VIII deficiency | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3B50.0 | Congenital alpha2 antiplasmin deficiency | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3B11 | Hereditary factor IX deficiency | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3B50.Y | Excessive release of tPA - [tissue-type plasminogen activator] | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3B50.1 | Congenital PAI-1 - [plasminogen activator inhibitor type 1] deficiency | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3B12 | Von Willebrand disease type 3 | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E08 | Malignant metastasis neoplasm involving skin of abdominal wall | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A50.02 | Alpha thalassaemia intermedia | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A50.00 | Heterozygous non-deletional alpha thalassaemia (αTα/αα and ααT/αα included) | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A50.01 | Haemoglobin Constant Spring | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E09 | Malignant neoplasm metastasis in peripheral nervous system | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E0Y | orbit metastasis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B55 | Rhabdomyosarcoma, primary site | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A00.3 | Acquired iron deficiency anaemia due to increased requirement in pregnancy | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A00.Y | microcytic anaemia NOS | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A02.3 | Megaloblastic anaemia due to decreased intestinal absorption of folate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A02.4 | megaloblastic anaemia due to drug-induced folate deficiency | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A08 | Colitis due to paratyphoid fever C | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A01.3 | Vitamin B12 deficiency anaemia due to intrinsic factor deficiency | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A02.Y | Tropical macrocytic anaemia | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A20.2 | Autoimmune haemolytic anaemia, mixed type, cold and warm | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A01.4 | Acquired megaloblastic anaemia due to vitamin B12 deficiency secondary to intestinal disease | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A20.0 | acute Lederer haemolytic anaemia | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A10.1 | Haemolytic anaemia due to adenosine deaminase excess | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A20.1 | cold hemagglutinin disease | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A10.0 | Haemolytic anaemias due to hexose monophosphate shunt or glutathione metabolism anomalies | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A21.2 | Glomerular disorders in haemolytic uraemic syndrome | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A10.2 | Hereditary pyropoikilocytosis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A21.1 | Neoplastic microangiopathic haemolytic anaemia | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A21.0 | nocturnal paroxysmal haemoglobinaemia | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A50.4 | Hereditary persistence of fetal haemoglobin, non-deletional | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E65.5 | Paget disease of nipple | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E67.0 | endometrial carcinoma in situ | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E67.1 | vulvar carcinoma in situ | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E67.2 | Carcinoma in situ of vagina | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2C10 | Malignant neoplasm of pancreas | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3B81.51 | Epithelial cyst of spleen | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3B81.5Y | Other specified splenic cyst | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3B81.50 | Pseudocyst of spleen | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3B81.7 | Infection of spleen | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3B81.6 | Subcapsular splenic haemorrhage | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B65.0 | Salivary gland-type carcinoma of palate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B65.1 | Squamous cell carcinoma of palate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B65.Y | Carcinoma of palate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A61 | Mixed phenotype acute leukaemias, T and myeloid, not elsewhere classified | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A09 | Infections due to other Salmonella | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B66.0 | Squamous cell carcinoma of other or unspecified parts of mouth | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B53.0 | fibromyxosarcoma of unspecified site | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B53.1 | Fibroblastic or myofibroblastic tumour of skin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B53.Y | pigmented dermatofibrosarcoma | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B66.Y | Other specified malignant neoplasms of other or unspecified parts of mouth | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B66.Z | primary malignant neoplasm of oral cavity | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3B21 | Haemorrhagic disorder due to circulating anticoagulants or coagulation factors inhibitors | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3B22 | Acquired factor XIII deficiency | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3B20 | acquired fibrinogenopenia | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E65.Y | Solid papillary carcinoma in situ of breast | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E65.Z | Breast cancer in situ | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A20.03 | Naegeli-type monocytic leukaemia | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A20.0Y | chronic myeloid leukaemia, BCR-ABL-positive in complete remission | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A20.0Z | chronic myeloid leukaemia, BCR-ABL-positive without mention of remission | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E69 | Carcinoma in situ of other or unspecified urinary organs | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B54.0 | malignant fibrous histiocytoma of unspecified site | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B54.Y | Undifferentiated pleomorphic sarcoma, other specified primary site | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B54.1 | Undifferentiated pleomorphic sarcoma of retroperitoneum or peritoneum | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A81.Y | Chlamydial colitis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A81.1 | Male chlamydial pelviperitonitis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A60.Y | Other specified acute myeloid leukaemias and related precursor neoplasms | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A81.0 | Chlamydial cervicitis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A60.Z | Acute myeloid leukaemias and related precursor neoplasms | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A60.36 | Acute megakaryoblastic leukaemia in complete remission | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A60.37 | Acute basophilic leukaemia | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B41.1 | Acute rheumatic endocarditis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B41.0 | acute rheumatic bacterial pericardium inflammation | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A60.38 | Acute myelofibrosis in complete remission | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B41.2 | acute rheumatic toxic myocarditis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A07.Z | enteric fever NOS | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A07.0 | typhoperitonitis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A07.Y | Typhoid colitis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A00.01 | chronic haemorrhagic anaemia | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A00.0Z | haemorrhagic anaemia | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3B10.Y | Other specified hereditary factor VIII deficiency | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3B10.1 | Hereditary factor VIII deficiency with anti-factor VIII inhibitor | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3B10.0 | Symptomatic form of haemophilia A in female carriers | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3B50.Z | Inherited fibrinolytic defects | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3B11.Y | Other specified hereditary factor IX deficiency | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3B11.Z | intravascular clotting defect | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3B11.0 | Symptomatic form of haemophilia B in female carriers | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A50.03 | Haemoglobin Bart hydrops fetalis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A50.0Y | Alpha thalassaemia myelodysplastic syndrome | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A50.0Z | alpha thalassaemia syndrome | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B80 | Malignant neoplasms of small intestine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B81 | Malignant neoplasms of appendix | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B90-2B9Y | Malignant neoplasms of large intestine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A94 | Anogenital herpes simplex infection | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B55.2 | Rhabdomyosarcoma of male genital organs | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B55.0 | Rhabdomyosarcoma of the oral cavity or pharynx | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B55.1 | Alveolar rhabdomyosarcoma | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A00.Z | Fe - [iron] deficiency anemia NOS | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A02.Z | Folic acid deficiency anaemia NOS | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A01.5 | Megaloblastic anaemia due to drug-induced vitamin B12 deficiency | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A20.3 | Donath-Landsteiner syndrome | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A10.3 | Familial pseudohyperkalaemia, Cardiff type | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A0Y | Neonatal bacterial intestinal infection | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A10.0Z | anaemia due to other disorders of glutathione metabolism | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A10.00 | anaemia due to haemolytic nonspherocytic (hereditary), type 1 | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A10.0Y | anaemia due to 6-phosphogluconate dehydrogenase deficiency | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A21.Y | Atypical haemolytic uraemic syndrome with anti-factor H antibodies | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A50.Y | Thalassaemia minor | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E67.3 | Carcinoma in situ of other or unspecified female genital organs | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E67.2Z | Squamous cell carcinoma in situ of vagina | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E67.22 | severe vaginal dysplasia, NEC | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E67.2Y | Other specified carcinoma in situ of vagina | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3B81.5Z | Splenic cyst or pseudocyst | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2C11 | Malignant neoplasms of other or ill-defined digestive organs | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3B81.71 | splenic abscess | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3B81.7Y | Other specified infection of spleen | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3B81.70 | septic spleen | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B67.1 | Squamous cell carcinoma of parotid gland | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B67.0 | Acinar cell carcinoma of parotid gland | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B67.Y | Other specified malignant neoplasms of parotid gland | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B65.Z | malignant neoplasm of upper or lower labial sulcus | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A09.Y | Pneumonia due to salmonella infection | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A09.Z | Sepsis due to Salmonella infection with septic shock | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A70-2A7Z | Precursor lymphoid neoplasms | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A09.0 | salmonellosis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B53.Z | Fibroblastic or myofibroblastic tumour, primary site | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B68 | Malignant neoplasms of submandibular or sublingual glands | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A01.Y | Addison anaemia | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3B2Y | Acquired stable factor deficiency | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E6A | Carcinoma in situ of the eye or ocular adnexa | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A80-2A8Z | Mature B-cell neoplasms | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B54.Z | Undifferentiated pleomorphic sarcoma, primary site | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E6B | Carcinoma in situ of thyroglossal duct | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A81.Z | other sexually transmitted chlamydial diseases | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B41.10 | Rheumatic aortitis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A60.39 | Myeloid sarcoma in complete remission | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B41.1Z | Acute rheumatic valvulitis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A60.3Y | Acute myeloid leukaemia, NOS by criteria of other types in complete remission | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B41.Y | Acute rheumatic coronary arteritis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B41.1Y | Active or acute tricuspid endocarditis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1B41.Z | acute RHD - [rheumatic heart disease] | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A0Z | Phlegmonous colitis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3B10.Z | Deficiency factor VIII with functional defect | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3B61 | Thrombophilia | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A01.3Z | Acquired megaloblastic anaemias due to vitamin B12 deficiency secondary to intrinsic factor deficiency | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A01.30 | Pernicious anaemia associated with other autoimmune disorders | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A01.3Y | Vitamin B12 deficiency anaemia associated with total gastrectomy | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A21.Z | acquired haemolytic anaemia, non-immune NOS | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A50.Z | thalassemia variants | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E67.11 | Extramammary Paget disease of vulva | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E67.12 | DVIN [Differentiated vulvar intraepithelial neoplasia] | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E67.13 | High grade squamous intraepithelial lesion of vulva NOS | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2C10.0 | Intraductal papillary-mucinous carcinoma of pancreas | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2C10.Y | Pancreatoblastoma | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2C10.1 | Increased secretion from endocrine pancreas of pancreatic polypeptide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A94.1 | Herpetic proctitis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A94.0 | Herpes simplex infection of male genital tract NOS | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A94.Z | anogenital HSV - [herpes simplex virus] infection | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3B81.8 | Torsion of spleen | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B55.Y | Myosarcoma of overlapping lesion of corpus uteri | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B55.Z | Rhabdomyosarcoma, primary site | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A03 | Other nutritional or metabolic anaemias | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3B21.0 | Haemorrhage due to thrombin inhibitor other than heparin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3B21.1 | Haemorrhage due to factor Xa inhibitor | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3B21.Y | Haemorrhagic disorder due to increase in anti-XIa | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A01.Z | Megaloblastic anaemia due to vitamin B12 deficiency | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A20.4 | Lymphocyte passenger syndrome, following organ transplantation | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3A10.Y | Atypical haemolytic uraemic syndrome with thrombomodulin anomaly | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E67.4 | PIN - [penile intraepithelial neoplasia] | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2E67.5 | carcinoma in situ prostate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3B81.9 | fibrotic spleen | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 3B81.7Z | interstitial splenitis | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 1A95 | Anogenital warts | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B67.Z | primary malignant neoplasm of parotid gland | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A60.3Z | AML - [Acute myeloid leukaemia] | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2B69 | Malignant neoplasms of tonsil | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A70 | Precursor B-lymphoblastic neoplasms | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs | 2A7Z | Precursor lymphoid neoplasms, unspecified |
Explanation of the columns that may appear on this page:
| Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
| System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance) |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |